We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Inion Oy | LSE:IIN | London | Ordinary Share | FI0009012918 | EUR0.03 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.36 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2008 18:15 | As per my previous post, this is now up 60% in a month and nobody seems to have noticed. | mikey34 | |
31/3/2008 21:14 | What going on here then? On the up? | darola | |
14/2/2008 10:00 | Today`s announcement of shares in lieu of part salaries gives the directors plenty of incentive to get the share price moving....theyre out of pocket at this price. | mikey34 | |
11/12/2007 16:59 | irenekent(Or anybody else who may be listening) Thought I might try to kick start some discussion here.Briefly, I`m surprised this has come back so far after seemingly beginning a recovery.There`s been some fairly promising news over the last few months.Comments? | mikey34 | |
06/7/2007 15:03 | Glad to see sales seem to be ahead of expectations. Remember that if implants don't have to be removed that saves on medical costs. I think insurance companies will be right behind these products as it could save them a fortune. One less operation means one less chance of MRSA etc! | irenekent | |
24/5/2007 08:22 | And clearance announced today for bio-dagradable implants for the repair of all skeletal fractures excluding spinal (seperate product) in the EU. This I think could be a significant achievement as Inion can now attack the central markets for fracture repair. Hoping for a rerating - assuming the sales team get their finger out! | irenekent | |
15/5/2007 10:02 | Another patent in the US today. There's life in this one yet! | irenekent | |
22/2/2007 15:02 | I think they are starting to deliver on their promises. The new products, just approved in the States appear to be a core addition to the range and should significantly expand their sales. Most people would choose a biodegradable splint, if given a choice, rather than carrying around a lump of metal for the rest of their life! The rise in the share price since the announcement seems to bear out my reading of the significance of this. I just hope that they don't get taken over by the like of Smith & Nephew before we have a chance to make a profit on these. | irenekent | |
21/2/2007 14:05 | good news today, I feel the momentum could be turning with this company.. | deep powder | |
31/1/2007 15:40 | spoke too soon, bit of life today... | deep powder | |
30/1/2007 15:59 | all very dull at the moment... | deep powder | |
19/1/2007 10:28 | This is a step in the right direction -------------------- Inion Oy 19 January 2007 Inion Expands Biodegradable Medical Implant Product Ranges in Europe Inion ANCHRONTM Plus Suture Anchor System receives CE Mark Tampere, Finland and Takeley, UK. 19 January 2007...Inion (LSE: IIN.L), a company focused on the development of novel biodegradable medical implants, has received CE Mark from the British Standards Institution (BSI) for the Inion ANCHRONTM Plus Suture Anchor device for both orthopaedic and sports medicine applications. This product received equivalent 510(k) regulatory clearance for marketing in the USA in November 2006. CE Mark is required by a number of accredited bodies to medical device manufacturers prior to commercial distribution in the European Union. Inion ANCHRONTM Plus with CP-FiberTM suture is an innovative biodegradable medical system for use in soft tissue to bone fixation (e.g. for repair of ligament/tendon rupture or detachment) and can be used for repairing a range of injuries. It has particular application in the shoulder, such as for rotator cuff and instability repairs (such as Bankart and SLAP lesions). The system can also be used to repair injuries in the elbow, ankle and knee. The high grade CP-FiberTM suture offers special advantages over traditional polyester sutures, including superior handling properties and increased strength. Inion ANCHRONTM Plus supersedes Inion ANCHRONTM, Inion's first biodegradable anchor system, and is a new addition to Inion's range of sports medicine devices made from the Company's proprietary Inion OPTIMATM range of biomaterials. This range includes Inion HEXALONTM, the world's first coloured biodegradable repair device for the cruciate ligaments in the knee; Inion TRINIONTM, the biodegradable meniscal screw for the repair of torn knee cartilage; and Inion ANCHRONTM, which received its CE Mark and 510(k) approval in 2005. Dr Auvo Kaikkonen, CEO of Inion commented, 'We are very pleased to have received a CE Mark for Inion ANCHRONTM Plus, allowing patients and surgeons across Europe access to a product that we believe offers a considerable performance advantage over other suture anchors currently available.' CP-FiberTM is a trademark of CP Medical, Inc., Portland, OR, USA. -Ends- Inion Oy Dr Auvo Kaikkonen, Chief Executive Officer Tel: +44 1279 874 222 Dr Kirk Andriano, VP of R&D Tel: +44 1223 394 206 Citigate Dewe Rogerson Tel: +44 207 638 9571 Mark Swallow / David Dible / Helena Galilee About Inion (www.inion.com) Inion Oy is a Finnish company that specializes in the development of biodegradable medical implants. The Inion core expertise and technology lies in the design and manufacture of innovative biodegradable plates, screws, pins and membranes that are used to enhance the healing of skeletal injuries (bone and soft tissue), such as those caused by trauma or by reconstructive surgery. Inion implants are made from its proprietary Inion OptimaTM family of biomaterials, with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Inion has developed and launched products in five strategic business areas - cranio-maxillofacial surgery, orthopaedic trauma, sports medicine, dental surgery and most recently in the spinal implant area - in nearly 50 countries worldwide. Inion was incorporated in early 2000 by an international team of experts in biodegradable materials and their clinical applications, and listed on the Official List of the UK Listing Authority in December 2004. The Company's has operations in the UK, R&D and production facilities in Tampere, Finland, and a US office in Oklahoma City, OK. This announcement includes 'forward-looking statements' which include all statements other than statements of historical facts, including, without limitation, those regarding the Group's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Group's products), and any statements preceded by, followed by or that include forward-looking terminology such as the words 'targets', 'believes', 'estimates', 'expects', 'aims', 'intends', 'will', 'can', 'may', 'anticipates', 'would', 'should', 'could' or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Group's control that could cause the actual results, performance or achievements of the Group to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Group's present and future business strategies and the environment in which the Group will operate in the future. Among the important factors that could cause the Group's actual results, performance or achievements to differ materially from those in forward-looking statements include those relating to Inion's funding requirements, regulatory approvals, reliance on third parties, intellectual property, key personnel and other factors. These forward-looking statements speak only as at the date of this announcement. The Group expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, prospective investors are cautioned not to rely on any forward-looking statement. | mattyfromtheblock | |
15/1/2007 13:27 | perky today... | deep powder | |
12/1/2007 15:52 | i still think it is in the bad but good news category, this is getting cleaned up for a deal....question is what price? | deep powder | |
10/1/2007 14:54 | Bad news particularly (imo etc) "The net loss for the year will be higher than expected as the Company has decided to make a number of one-time write-offs. The value of these items is expected to be around Euro7.0 million. This includes a deferred tax asset of Euro4.1 million." The write off of the deferred tax asset would apparently imply that the Board do not expect the Company to be profit making in the forseeable future - Could an accountant double check me on this and if my interpretation is wrong I will amend this posting. | pugugly | |
02/1/2007 16:23 | Very quiet here, what's happened to all the 'takeover' boys? | deep powder | |
27/12/2006 15:33 | latest rns, bad but good news?? | deep powder | |
15/12/2006 05:33 | grasping at straws but stock seems to be forming a base, last news announcements more positive, interesting to see result of strategic review. any fresh thoughts here? | deep powder | |
29/11/2006 08:37 | change of CEO, it had to happen Dr Auvo Kaikkonen was obviously useless! Don't hold but very undervalued. | eddiegoldstein | |
24/11/2006 13:54 | its funny...barclays are quoting 21-27 for 15000 shares yet they are 24-24 on advfn. | currypata kai | |
24/11/2006 11:28 | while things seem bleak surely the co still has substantial cash | trawl | |
24/11/2006 11:09 | Looks like it's another classic FLOP, everyone has made a nice pile on this share except for the poor old punters who have been sold hype...god knows where the bottom is on this one probably 2p, wish my CFD was still in place! | jotoha1 | |
24/11/2006 09:51 | Who would buy them? They don't own anything that is unique. The CEO has yet to be fired for a catalogue of failures. | simon gordon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions